Title for MeetingAbstracts
Alphabetical listing of titles
-
Activity of the New Glycopeptide Oritavancin (LY333328; ORI) in a Model of Staphylococcus aureus Intraphagocytic Infection in Comparison with Telithromycin (TEL) and Moxifloxacin (MXF).
-
Activity of the New Oxazolidinone, AZD2563, against Selected Recent North American Isolates of Streptococcus pneumoniae.
-
Activity of the protease inhibitor Ro 31-8959 on acute, chronic and latent HIV infection.
-
Activity of the Pyrroloaryl-Substituted Oxazolidinones RWJ-334181 and RWJ-337813 against Mycobacteria and Drug-Resistant Gram-Positive Bacteria.
-
Activity of the Schiff-Base-Forming Compound Tucaresol against Experimental Visceral Leishmaniasis.
-
Activity of the triazole SCH51048 (SCH) against coccidioides immitis in vitro and in vivo.
-
Activity of thymidine kinase in PBMCS of HIV-1-infected patients correlates with disease progression.
-
Activity of Tigecycline against 2206 Recent Bacteremia Isolates in the UK and Eire.
-
Activity of triciribine (TCN) against HIV-1 requires cellular phosphorylation and inhibition of a viral gene product.
-
Activity of Two Novel Antibiotics against Bacillus spp., Clostridium spp., Corynebacterium jeikeium and Listeria monocytogenes.
-
Activity of Vancomycin (V) and Teicoplanin (T) In Vitro and in Experimental Endocarditis Due to Staphylococcus aureus Susceptible or Intermediate to Glycopeptides (GISA).
-
Activity of Voriconazole (V), Itraconazole (I) and Amphotericin B (A) In Vitro against 577 Molds from the Voriconazole Phase III Clinical Studies.
-
Activity of Voriconazole (V), Itraconazole (I), Fluconazole (F) and Amphotericin B (A) In Vitro against 1575 Yeasts from the Voriconazole Phase III Clinical Studies.
-
Activity of voriconazole against Cryptococcus neoformans var. gattii vs var. neoformans: effect of human serum.
-
Activity-Based Costing for radiotherapy: the cost of activities.
-
Activity-Based Costing in radiotherapy: correlation between workload and treatment costs per organ system.
-
Activty of MK-0826 Versus b-Lactamase Producers.
-
ACTUA a new Latin Mediterranean experience: coping with HIV/AIDS within the structure of a NGO.
-
Actual costs of HIV/AIDS care.
-
Acupuncture & natural essence therapy.
-
Acupuncture cross-over trial: can acupuncture effectively control side-effects of HIV-combination therapy?
-
Acupuncture for low back pain: a systematic review.
-
Acupuncture for the Prevention of Migraine Headaches: A Cost-Utility Analysis.
-
Acupuncture in a group setting reduces the pain and neuropathic symptoms associated with HIV infection.
-
Acupuncture is associated with greater self-reported adherence to antiretroviral therapy.
-
Acupuncture treatment in people with HCV and HIV co-infection and elevated transaminases.
-
Acupuncture trial in side-effect management and adherence enhancement.
-
Acupuncture/an alternative to acting out or violent behavior in HIV infected inmates.
-
Acupuncture: evidence from systematic reviews.
-
Acute and chronic diarrhea (AD, CD) in HIV-1 infected patients, Lusaka, Zambia and Houston, Texas, 1992.